- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
USFDA nod to physiotherapy monitoring device Pheezee
The device generates reports, for the first time in the field of physiotherapy, enabling patients to track their recovery.
Hyderabad: Startoon Labs Private Limited, a Hyderabad-based medical device R&D, Engineering and Manufacturing Company has announced it has received US FDA (The US Food and Drug Administration) (510 K Exempt) clearance for its revolutionary physiotherapy monitoring device ‘ Pheezee’, the first of kind in the world.
Pheezee is certified for electrical and environmental safety as per international standards and is a registered medical device with the Central Drugs Standard Control Organization (CDSCO) and the device is a game-changer in the field of physiotherapy and rehabilitation, Startoon Labs, one of the most vibrant startups among 4,000 startups in Telangana, said in a release here.
Pheezee is a patented technology, capable of measuring the surface Electromyogram (sEMG) of bulk muscles and Range of motion (ROM) of primary joints simultaneously, to determine joint health, making it a one-of-a-kind product in the world with this capability, said Suresh Susurla, Founder & CEO, Startoon Labs.
The device is helpful in assessing joint health during physiotherapy post musculoskeletal, neurological, spinal cord injuries and neuro-ailments such as paralysis, hemiplegia, paraplegia, muscular dystrophy, he claimed.
It generates reports, for the first time in the field of physiotherapy, enabling patients to track their recovery.
Pheezee, being an IOT-enabled device, enables telerehabilitation of the patients and allows them to continue doing physiotherapy sessions at home and still keep the referring surgeon updated about the progress, he said.
It is a revolutionary device set to transform the way assessments, monitoring and tracking of recovery is done in the field of physiotherapy, says Mythreyi Kondapi Co-founder of the medical technology startup.
The flagship product of the company already enjoys national and international recognition and with USFDA’s nod, its reach is going to be widened even further. Now it will demonstrate its performance in the USA and many other global markets, he said.
It is a proud moment not just for us, but for the entire MedTech startup community in the state that Pheezee is now a globally accepted Made in Telangana product, Suresh, a well-acclaimed professional who has 11 international publications to his credit (co-authored), said.
As a part of the rapidly growing MedTech industry in India, valued at $10.86 billion in 2020, Startoon Labs is at the forefront of the digital technology segment. The sector is poised for growth, at a CAGR of 37 percent and to reach $50 billion by 2025, he added.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story